Investors

AddLife shares are traded on Nasdaq Stockholm, Nordic Large Cap

ADD Lonsamhet Vit

The share

Chart Bar

Financial reports and presentations

Calendar

Humans

Corporate governance

  • Interim Report Q1 2025

    Investors, analysts and the media are invited to a video conference where CEO Fredrik Dalborg and CFO Christina Rubenhag will present the interim report. The presentation will be in English and take about 20 minutes, after which there will be an opportunity to ask questions. It will be recorded and made available online.


    The report is released Friday, April 25 2025, at 07.45 a.m 
    Video conference at 9:00 a.m

    Video conference
    Christina Rubenhag Fredrik Dalborg 2023
  • Significant improvements in all prioritised areas

    The companies within AddLife have done a fantastic job over the past year, achieving significant improvements in all priority areas. A focused effort to improve margins has yielded clear results. Our organic growth exceeds market growth, confirming our leading positions in rapidly growing market niches, our continuous development of the product portfolio, and our ability to gain market share.

    ANNUAL REPORT 2024
    VD Ord Fredrik Dalborg Addlife

Listen to our latest presentation

 

AddLife creates value

The laboratory and medical technology market is relatively insensitive to economic fluctuations. Growth tends to be stable and is mainly driven by population growth and an ageing population. These trends increase the demand for AddLife's healthcare and research products. Historically, the markets where we operate have grown at an annual rate of 2-4 percent.

AddLife’s subsidiaries are strongly cash generative, which gives financial opportunity for acquisitions and investments.

ADD Lonsamhet Vit

AddLife has substantial experience of acquisitions, identifying candidates and completing successful transactions.

ADD Ansvar Vit

AddLife’s subsidiaries have strong sales organisations with high technological expertise and long term customer relationships.

ADD Engagemang Vit

Target fulfilment 2024

Earnings growth

Profitability

Dividend

Contact us!

The investor pages contain all published financial information to facilitate investment decisions.

We are happy to assist you in understanding our business and financial results. Please do not hesitate to contact us if you would like more information, or if you have any suggestions for improving our service.

Contact: [email protected]

IR- and press contacts

Fredrik Dalborg (2)

Fredrik Dalborg

CEO

[email protected]

Christina Rubenhag

Christina Rubenhag

CFO

[email protected]

Julie Oleary

Julie O'Leary

Investor Relations Manager

[email protected]

Subscribe